Journal ArticleOPEN ACCESS

Early Molecular Response and Female Sex Strongly Predict Achievement of Stable Undetectable BCR-ABL1, a Criterion for Imatinib Discontinuation in Patients with CML

  • Branford S
  • Ross D
  • Prime J
  • et al.
Blood (2012) 120(21) 165-165
DOI: 10.1182/blood.v120.21.165.165
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract 165

Cite

CITATION STYLE

APA

Branford, S., Ross, D., Prime, J., Field, C., Altamura, H., Yeoman, A., … Hughes, T. (2012). Early Molecular Response and Female Sex Strongly Predict Achievement of Stable Undetectable BCR-ABL1, a Criterion for Imatinib Discontinuation in Patients with CML. Blood, 120(21), 165–165. https://doi.org/10.1182/blood.v120.21.165.165

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free